138 related articles for article (PubMed ID: 11227723)
1. [Myocardial metabolism abnormalities during ischemia and reperfusion].
Argaud L; Ovize M
Arch Mal Coeur Vaiss; 2000 Jan; 93(1):87-90. PubMed ID: 11227723
[TBL] [Abstract][Full Text] [Related]
2. Cardiac energetics during ischaemia and the rationale for metabolic interventions.
Stanley WC
Coron Artery Dis; 2001 Feb; 12 Suppl 1():S3-7. PubMed ID: 11286306
[TBL] [Abstract][Full Text] [Related]
3. Contribution of protons to post-ischemic Na(+) and Ca(2+) overload and left ventricular mechanical dysfunction.
Clanachan AS
J Cardiovasc Electrophysiol; 2006 May; 17 Suppl 1():S141-S148. PubMed ID: 16686669
[TBL] [Abstract][Full Text] [Related]
4. Targets for modulation of fatty acid oxidation in the heart.
Lopaschuk GD
Curr Opin Investig Drugs; 2004 Mar; 5(3):290-4. PubMed ID: 15083595
[TBL] [Abstract][Full Text] [Related]
5. Importance of glycolytically derived ATP for Na+ loading via Na+/H+ exchange during metabolic inhibition in guinea pig ventricular myocytes.
Satoh H; Sugiyama S; Nomura N; Terada H; Hayashi H
Clin Sci (Lond); 2001 Sep; 101(3):243-51. PubMed ID: 11524041
[TBL] [Abstract][Full Text] [Related]
6. Energetic myocardial metabolism and oxidative stress: let's make them our friends in the fight against heart failure.
Scolletta S; Biagioli B
Biomed Pharmacother; 2010 Mar; 64(3):203-7. PubMed ID: 19954925
[TBL] [Abstract][Full Text] [Related]
7. Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation.
Dyck JR; Cheng JF; Stanley WC; Barr R; Chandler MP; Brown S; Wallace D; Arrhenius T; Harmon C; Yang G; Nadzan AM; Lopaschuk GD
Circ Res; 2004 May; 94(9):e78-84. PubMed ID: 15105298
[TBL] [Abstract][Full Text] [Related]
8. [Intermediate myocardial metabolism. Changes in ischemia, diabetes and hyperthyroidism].
Feuvray D; Khandoudi N; Lagadic-Gossmann D; Besse S
Arch Mal Coeur Vaiss; 1988 Oct; 81 Spec No():29-33. PubMed ID: 3145722
[TBL] [Abstract][Full Text] [Related]
9. [Metabolic considerations in the treatment of coronary disease in diabetic patients].
Piot C
Diabetes Metab; 2001 Nov; 27(5 Pt 2):S25-9. PubMed ID: 11910982
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of elemental composition (Na/K/Ca) of muscle cells in ischemia in a model of the perfused heart].
Pogorelov AG; Pogorelova VN; Dubrovkin MI; Demin IP
Tsitologiia; 2000; 42(1):62-5. PubMed ID: 10709254
[TBL] [Abstract][Full Text] [Related]
11. A comparison between ranolazine and CVT-4325, a novel inhibitor of fatty acid oxidation, on cardiac metabolism and left ventricular function in rat isolated perfused heart during ischemia and reperfusion.
Wang P; Fraser H; Lloyd SG; McVeigh JJ; Belardinelli L; Chatham JC
J Pharmacol Exp Ther; 2007 Apr; 321(1):213-20. PubMed ID: 17202401
[TBL] [Abstract][Full Text] [Related]
12. Aerobic vs anaerobic metabolism during ischemia in heart muscle.
Das DK; Engelman RM; Rousou JA; Breyer RH
Ann Chir Gynaecol; 1987; 76(1):68-76. PubMed ID: 3592561
[TBL] [Abstract][Full Text] [Related]
13. Fatty acids attenuate insulin regulation of 5'-AMP-activated protein kinase and insulin cardioprotection after ischemia.
Folmes CD; Clanachan AS; Lopaschuk GD
Circ Res; 2006 Jul; 99(1):61-8. PubMed ID: 16741157
[TBL] [Abstract][Full Text] [Related]
14. Optimizing cardiac energy metabolism: how can fatty acid and carbohydrate metabolism be manipulated?
Lopaschuk GD
Coron Artery Dis; 2001 Feb; 12 Suppl 1():S8-11. PubMed ID: 11286307
[TBL] [Abstract][Full Text] [Related]
15. Metabolic therapy for the treatment of ischemic heart disease: reality and expectations.
Wang W; Lopaschuk GD
Expert Rev Cardiovasc Ther; 2007 Nov; 5(6):1123-34. PubMed ID: 18035928
[TBL] [Abstract][Full Text] [Related]
16. Fatty acid translocase/CD36 deficiency does not energetically or functionally compromise hearts before or after ischemia.
Kuang M; Febbraio M; Wagg C; Lopaschuk GD; Dyck JR
Circulation; 2004 Mar; 109(12):1550-7. PubMed ID: 15023869
[TBL] [Abstract][Full Text] [Related]
17. [Cellular sequelae of myocardial ischemia].
Richardt G; Tölg R
Z Kardiol; 1997; 86 Suppl 1():23-32. PubMed ID: 9173719
[TBL] [Abstract][Full Text] [Related]
18. Metabolic energy metabolism in diabetes: therapeutic implications.
Pogatsa G
Coron Artery Dis; 2001 Feb; 12 Suppl 1():S29-33. PubMed ID: 11286305
[TBL] [Abstract][Full Text] [Related]
19. Targeting fatty acid and carbohydrate oxidation--a novel therapeutic intervention in the ischemic and failing heart.
Jaswal JS; Keung W; Wang W; Ussher JR; Lopaschuk GD
Biochim Biophys Acta; 2011 Jul; 1813(7):1333-50. PubMed ID: 21256164
[TBL] [Abstract][Full Text] [Related]
20. Ischemic preconditioning accelerates the fatty acid oxidation of rat hearts.
Matsuki A; Nozawa T; Igawa A; Igarashi N; Nakadate T; Fujii N; Inoue H
Int J Cardiol; 2009 Mar; 132(3):405-10. PubMed ID: 18495272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
